The global porcine vaccines market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for porcine vaccines in emerging economies such as China and India, which are witnessing an increase in swine population and pork production. In addition, the increasing awareness about animal welfare and food safety among consumers has led to increased demand for porcine vaccines in developed countries such as North America and Europe.
Live attenuated vaccines accounted for the largest share of the global porcine vaccine market in 2017, followed by inactivated vaccines. Live attenuated vaccines are preferred over other types due to their ability to induce long-lasting immunity against various diseases without causing any adverse effects on animals or humans; they also have a lower cost than other types of vaccine due to their low manufacturing cost. Inactivated vaccines are used when live attenuated vaccine cannot be administered because it may cause adverse effects on animals or humans; they also provide protection against various diseases that live attenuated vaccine cannot protect against such as Porcine Circoviruses (PCV).
Swine fever vaccinations accounted for the largest share of the global porcine vaccine market in 2017, followed by swine flu vaccinations and PCV vaccinations respectively. Swine fever vaccination protects pigs from hog cholera caused by bacteria called Pasteurella multocida; it is administered through intramuscular injection or oral administration depending on its type (live attenuated or killed). Swines flu vaccination protects pigs from influenza virus that causes respiratory disease; it is administered through intramuscular injection only (inactivated). PCV vaccination protects pigs from Porcinal Circovirus Type 2 (PCV2) which causes diarrhea among piglets; it is administered through intramuscular injection only (inactivated).
- The global Porcine Vaccines market is expected to grow at a CAGR of 5.5% during the forecast period, 2018-2025.
- Increasing demand for Porcine Vaccines in emerging economies such as China and India is one of the major factors driving the growth of this market.
- Increasing awareness about Porcine Vaccines among farmers and veterinarians is also driving the growth of this market.
- The increasing number of pig farms in developing countries such as China, India, Brazil, and Mexico are also contributing to the growth of this market.
- The increasing demand for pork meat from consumers in developed countries such as Japan and South Korea is also driving the growth of this market.
Industry Growth Insights published a new data on “Porcine Vaccines Market”. The research report is titled “Porcine Vaccines Market research by Types (Live Attenuated Vaccines, Inactivated Vaccines, Other), By Applications (Swine Fever Vaccines, Swine Flu Vaccines, Porcine Circoviruses, Other), By Players/Companies WINSUN, CAHIC, Merial , MSD Animal Health (Merck), Chopper Biology, Ceva, ChengDu Tecbond, HVRI, Ringpu Biology, Qilu Animal Health, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, 18Institutul Pasteur, MVP, Tecon”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Porcine Vaccines Market Research Report
By Type
Live Attenuated Vaccines, Inactivated Vaccines, Other
By Application
Swine Fever Vaccines, Swine Flu Vaccines, Porcine Circoviruses, Other
By Companies
WINSUN, CAHIC, Merial , MSD Animal Health (Merck), Chopper Biology, Ceva, ChengDu Tecbond, HVRI, Ringpu Biology, Qilu Animal Health, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, 18Institutul Pasteur, MVP, Tecon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Porcine Vaccines Market Report Segments:
The global Porcine Vaccines market is segmented on the basis of:
Types
Live Attenuated Vaccines, Inactivated Vaccines, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Swine Fever Vaccines, Swine Flu Vaccines, Porcine Circoviruses, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- WINSUN
- CAHIC
- MerialÂ
- MSD Animal Health (Merck)
- Chopper Biology
- Ceva
- ChengDu Tecbond
- HVRI
- Ringpu Biology
- Qilu Animal Health
- DHN
- CAVAC
- Komipharm
- Agrovet
- Bioveta
- Jinyu Bio-Technology
- 18Institutul Pasteur
- MVP
- Tecon
Highlights of The Porcine Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Attenuated Vaccines
- Inactivated Vaccines
- Other
- By Application:
- Swine Fever Vaccines
- Swine Flu Vaccines
- Porcine Circoviruses
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Porcine Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Porcine vaccines are a type of vaccine that is made from the blood, tissues, and organs of pigs. Porcine vaccines can help protect people against diseases like swine flu and porcine epidemic diarrhea (PED).
Some of the key players operating in the porcine vaccines market are WINSUN, CAHIC, Merial‚Â , MSD Animal Health (Merck), Chopper Biology, Ceva, ChengDu Tecbond, HVRI, Ringpu Biology, Qilu Animal Health, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, 18Institutul Pasteur, MVP, Tecon.
The porcine vaccines market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Porcine Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Porcine Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Porcine Vaccines Market - Supply Chain
4.5. Global Porcine Vaccines Market Forecast
4.5.1. Porcine Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Porcine Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Porcine Vaccines Market Absolute $ Opportunity
5. Global Porcine Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Porcine Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Attenuated Vaccines
5.3.2. Inactivated Vaccines
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Porcine Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Porcine Vaccines Market Size and Volume Forecast by Application
6.3.1. Swine Fever Vaccines
6.3.2. Swine Flu Vaccines
6.3.3. Porcine Circoviruses
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Porcine Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Porcine Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Porcine Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Porcine Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Porcine Vaccines Demand Share Forecast, 2019-2026
9. North America Porcine Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Porcine Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Porcine Vaccines Market Size and Volume Forecast by Application
9.4.1. Swine Fever Vaccines
9.4.2. Swine Flu Vaccines
9.4.3. Porcine Circoviruses
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Porcine Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Attenuated Vaccines
9.7.2. Inactivated Vaccines
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Porcine Vaccines Demand Share Forecast, 2019-2026
10. Latin America Porcine Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Porcine Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Porcine Vaccines Market Size and Volume Forecast by Application
10.4.1. Swine Fever Vaccines
10.4.2. Swine Flu Vaccines
10.4.3. Porcine Circoviruses
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Porcine Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Attenuated Vaccines
10.7.2. Inactivated Vaccines
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Porcine Vaccines Demand Share Forecast, 2019-2026
11. Europe Porcine Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Porcine Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Porcine Vaccines Market Size and Volume Forecast by Application
11.4.1. Swine Fever Vaccines
11.4.2. Swine Flu Vaccines
11.4.3. Porcine Circoviruses
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Porcine Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Attenuated Vaccines
11.7.2. Inactivated Vaccines
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Porcine Vaccines Demand Share, 2019-2026
12. Asia Pacific Porcine Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Porcine Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Porcine Vaccines Market Size and Volume Forecast by Application
12.4.1. Swine Fever Vaccines
12.4.2. Swine Flu Vaccines
12.4.3. Porcine Circoviruses
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Porcine Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Attenuated Vaccines
12.7.2. Inactivated Vaccines
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Porcine Vaccines Demand Share, 2019-2026
13. Middle East & Africa Porcine Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Porcine Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Porcine Vaccines Market Size and Volume Forecast by Application
13.4.1. Swine Fever Vaccines
13.4.2. Swine Flu Vaccines
13.4.3. Porcine Circoviruses
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Porcine Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Attenuated Vaccines
13.7.2. Inactivated Vaccines
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Porcine Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Porcine Vaccines Market: Market Share Analysis
14.2. Porcine Vaccines Distributors and Customers
14.3. Porcine Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. WINSUN
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CAHIC
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merial
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MSD Animal Health (Merck)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Chopper Biology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ceva
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ChengDu Tecbond
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. HVRI
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ringpu Biology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Qilu Animal Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DHN
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CAVAC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Komipharm
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Agrovet
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Bioveta
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Jinyu Bio-Technology
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. 18Institutul Pasteur
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. MVP
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Tecon
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
